The effect of Naproxen in recovery and reducing mortality in patients with COVID-19
Phase 4
Recruiting
- Conditions
- COVID-19, virus identifiedcovid-19 disease.U07.1
- Registration Number
- IRCT20200410047009N1
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 101
Inclusion Criteria
Patients whose SARS-CoV-2 infection has been confirmed using PCR
Age over 18 years
The conscious consent form must be completed and signed by the patient or his companion
The patient should participate in the research voluntarily
Exclusion Criteria
High creatinine and kidney problems
In gastrointestinal ulcers
Other conditions of contraindications to the use of Naproxen
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Recovery in COVID-19 patients. Timepoint: At the beginning (day zero) and the end of the treatment period (day 10). Method of measurement: Examination of clinical signs.;Mortality rate in COVID-19 patients. Timepoint: At the end of treatment period. Method of measurement: The percentage of mortality rate in the study population.
- Secondary Outcome Measures
Name Time Method